Strategies in treating male breast cancer (Q36719688)

15 August 2017

1 reference

title

Strategies in treating male breast cancer (English)

1 reference

15 August 2017

1 reference

Bruno Cutuli

1

1 reference

PubMed ID

17257089

15 August 2017

language of work or name

English

0 references

publication date

1 February 2007

1 reference

Expert Opinion on Pharmacotherapy

15 August 2017

1 reference

15 August 2017

8

1 reference

15 August 2017

2

1 reference

15 August 2017

193-202

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.2.193

15 August 2017

1 reference

Male breast carcinoma: a review of 229 patients who presented to the Princess Margaret Hospital during 40 years: 1955-1996.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.2.193

Carcinoma of the breast in males: a multiinstitutional survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.2.193

Male breast cancer: results of the treatments and prognostic factors in 397 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.2.193

Male breast cancer--an andrological disease: risk factors and diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.2.193

Review article: epidemiology of male breast cancer. A meta-analysis of published case-control studies and discussion of selected aetiological factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.2.193

Male breast carcinoma. I. A study of the total material reported to the Swedish Cancer Registry 1958-1967 with respect to clinical and histopathologic parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.2.193

Histologic types and hormone receptors in breast cancer in men: a population-based study in 282 United States men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.2.193

Ductal carcinoma in situ of the male breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.2.193

Ductal carcinoma in situ of the male breast. Analysis of 31 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.2.193

In situ male breast carcinoma in the Surveillance, Epidemiology, and End Results database of the National Cancer Institute.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.2.193

Estrogen receptor content in malignant breast tumors in men--a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.2.193

Adjuvant systemic therapy for male breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.2.193

Current management of male breast cancer. A review of 104 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.2.193

American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.2.193

Sentinel lymph node biopsy in male breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.2.193

Male breast cancer: a 13-year review of 89 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.2.193

Post-mastectomy radiation in male breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.2.193

Evidence-based indications for postmastectomy irradiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.2.193

The use of radiotherapy after mastectomy: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.2.193

Optimizing locoregional control and survival for women with breast cancer: a review of current developments in postmastectomy radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.2.193

Study of failure pattern among high-risk breast cancer patients with or without postmastectomy radiotherapy in addition to adjuvant systemic therapy: long-term results from the Danish Breast Cancer Cooperative Group DBCG 82 b and c randomized studie

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.2.193

Risk factors for locoregional recurrence among breast cancer patients: results from International Breast Cancer Study Group Trials I through VII.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.2.193

Recursive partitioning analysis of locoregional recurrence patterns following mastectomy: implications for adjuvant irradiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.2.193

Male breast cancer: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.2.193

Tamoxifen administration is associated with a high rate of treatment-limiting symptoms in male breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.2.193

Hormonal therapy for male breast cancer: A different approach for a different disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.2.193

Steroid hormone receptor expression in male breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.2.193

Efficacy of anastrozole in male breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.2.193

Successful use of letrozole in male breast cancer: a case report and review of hormonal therapy for male breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.2.193

Carcinoma of the male breast: analysis of prognosis compared with matched female patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.2.193

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.2.193

Her-2/neu gene amplification and protein expression in primary male breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.2.193

Male breast carcinoma: correlation of ER, PR, Ki-67, Her2-Neu, and p53 with treatment and survival, a study of 65 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.2.193

Molecular markers in male breast carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.2.193

Second primary malignancies in patients with male breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.2.193

Is male breast cancer similar or different than female breast cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.2.193

Undertreatment strongly decreases prognosis of breast cancer in elderly women

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.2.193

Breast cancer treatment guidelines in older women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.2.193

A French national survey on infiltrating breast cancer: analysis of clinico-pathological features and treatment modalities in 1159 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.2.193

Adjuvant systemic treatment of early breast cancer: the NORA study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.2.193

21 January 2018

Identifiers

DOI

10.1517/14656566.8.2.193

1 reference

15 August 2017

1 reference

PubMed ID

17257089